CD8A and Autoimmunity: A recent study showed that treatment of MRL-lpr mice with5-azacytidine (5-Aza), a chemical analogue of cytidine that inhibits DNAmethylation, enhanced autoimmunity, whereas targeting 5-Aza to only CD4+ or CD8 Tcells alleviated disease (45).